Navigation Links
USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical

SAN CLEMENTE, Calif., May 12 /PRNewswire/ -- USGI Medical, Inc. (USGI), the leader in incisionless surgery, announced today that the company has licensed its incisionless surgery technology to Intuitive Surgical (Nasdaq: ISRG) for use in medical robotics applications. Financial terms of the deal were not disclosed.

"We've been impressed by USGI's technical and clinical development including their intellectual property," said Gary Guthart, president and chief operating officer of Intuitive Surgical Inc. "The combination of USGI's intellectual property with Intuitive's robotic capabilities allows for compelling possibilities for future robotic products."

USGI's incisionless surgery platform, the EndoSurgical Operating System(TM) (EOS), is designed to address a wide range of surgical indications. Surgeons and gastroenterologists currently use the EOS to perform endolumenal (procedures within the GI tract) and translumenal procedures through the body's natural orifices (these are commonly referred to as "NOTES" or Natural Orifice Translumenal Endoscopic Surgery). Eliminating skin incisions may reduce the risk of infection and associated complications and may result in less post-operative pain, faster recovery time and no abdominal scars for patients.

"This agreement with Intuitive Surgical is another step forward in our efforts to establish the EOS as the leading, most complete surgical platform for Incisonless Surgery," said USGI Medical CEO Eugene Chen. "Many of the country's leading physicians have used the EOS to complete a wide range of groundbreaking incisionless procedures. We believe that mechanical and robotic solutions complement each other and together will advance and expand this field to a wider group of procedures and patients."

Surgeons have used USGI's EOS to complete the first transgastric gall bladder and appendix removals in the U.S. and to close the access incision (gastrotomy) in the stomach wall during NOTES procedures. Many surgeons and gastroenterologists use the EOS routinely to perform an incisionless procedure to reduce the size of the gastric pouch and stoma in patients who experience weight regain after gastric bypass surgery.

About USGI Medical

USGI Medical is the leader in Incisionless Surgery. USGI's EndoSurgical Operating System(TM) (EOS) provides surgeons the operating platform and specialized tools they need to perform surgery through a patient's mouth, other natural orifice, or single incision, reducing or eliminating the need for external incisions into the abdomen. Operating through the body's natural orifices offers promise for less pain, shorter hospital stays, reduced risk of wound infection and no external scars -- and is rapidly becoming an option demanded by patients and healthcare providers. It has been estimated that over 4 million procedures currently performed using invasive means can be addressed with an incisionless approach in the future, creating a $5 billion opportunity for USGI.

USGI Endosurgical Operating System(TM)

USGI's Endosurgical Operating System(TM) (EOS) is designed to provide surgeons and gastroenterologists the tools they need to convert current operations to incisionless procedures. The system:
-- Facilitates access and visualization of the operating field via the

body's natural orifices

-- Provides a stable operating platform to enhance surgical precision and


-- Allows the use of multiple, robust instruments much like in


-- Enables rapid, durable suturing and wound closure

The EOS includes the TransPort(TM) Multi-lumen Operating Platform, the g-Prox(R) Tissue Grasper and Approximation Device, expandable tissue anchors, and a variety of specialized instruments, all of which have received U.S. Food and Drug Administration (FDA) 510(k) clearance. To date, the EOS has been used in over 100 incisionless procedures in the U.S.

USGI Contacts:


Eugene Chen, CEO

USGI Medical


Fern Lazar

Lazar Partners


Hollister Hovey

Lazar Partners


SOURCE USGI Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... new scientific discoveries deepen our understanding of how cancer ... challenges in better using that knowledge to guide treatment ... children continue to survive pediatric cancer, that counseling may ... John M. Maris, M.D ., a pediatric oncologist ... --> John M. Maris, M.D ., ...
(Date:11/17/2015)... -- Paris , qui s,est ... Paris , qui s,est tenu du 17 ... de l,innovation biométrique, a inventé le premier scanner couplé, ... la même surface de balayage. Jusqu,ici, deux scanners étaient ... empreintes digitales. Désormais, un seul scanner est en mesure ...
Breaking Biology News(10 mins):